Stocks News

LAST PRICE
51.3200
TODAY'S CHANGE (%)
Trending Down-0.3800 (-0.7350%)

Bid / Lots
50.1000/ 2
Ask / Lots
52.4900/ 1
Open / Previous Close
51.6500 / 51.7000
Day Range
Low 50.5500
High 51.8732
52 Week Range
Low 42.7500
High 64.4750
Volume
400,585
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 14, 2024
- LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: LIVN
  
  LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
  LONDON--(BUSINESS WIRE)--November 14, 2024--
  LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present a general business update during fireside chats at the three following healthcare conferences in New York in November and December:
Nov 12, 2024
- DJ LivaNova Price Target Maintained With a $75.00/Share by Needham, from 11:07AM ET on Tuesday Nov 12, 2024 by Dow Jones
  11:07AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: LIVN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/LIVN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 12, 2024 11:07 ET (16:07 GMT)
Nov 11, 2024
- LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints, from 4:05PM ET on Monday Nov 11, 2024 by Dow Jones
  4:05PM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: LIVN
  
  LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
  
  Top-line results compared to baseline at six months:
  
  Median apnea-hypopnea index reduction of 66.2%
Oct 31, 2024
- DJ LivaNova Is Maintained at Outperform by Mizuho, from 10:41AM ET on Thursday Oct 31, 2024 by Dow Jones
  10:41AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: LIVN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/LIVN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 10:41 ET (14:41 GMT)
- DJ LivaNova Is Maintained at Outperform by Baird, from 7:51AM ET on Thursday Oct 31, 2024 by Dow Jones
  7:51AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: LIVN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/LIVN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 07:51 ET (11:51 GMT)

Nov 20, 2024
- Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing, from 5:31PM ET on Wednesday Nov 20, 2024 by MT Newswires
  5:31PM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: NARI
Nov 19, 2024
- DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 12:16PM ET on Tuesday Nov 19, 2024 by Dow Jones
  12:16PM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: WRBY
- INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Newsfile
  8:52AM ET on Tuesday Nov 19, 2024 by Newsfile
  Companies Mentioned: NARI
- INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:52AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: NARI
Nov 18, 2024
- CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference, from 4:05PM ET on Monday Nov 18, 2024 by Dow Jones
  4:05PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: CNMD
Nov 13, 2024
- Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Newsfile
  1:09PM ET on Wednesday Nov 13, 2024 by Newsfile
  Companies Mentioned: NARI
- Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: NARI
Nov 8, 2024
- DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 6:09PM ET on Friday Nov 08, 2024 by Dow Jones
  6:09PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: WRBY
- UBS Adjusts Price Target on Warby Parker to $20 From $15, Maintains Neutral Rating, from 11:55AM ET on Friday Nov 08, 2024 by MT Newswires
  11:55AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: WRBY
- DJ Warby Parker Is Maintained at Overweight by Piper Sandler, from 9:41AM ET on Friday Nov 08, 2024 by Dow Jones
  9:41AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: WRBY

LivaNova PLC
NASDAQ:LIVNUnited States

Search Criteria

Nov 14, 2024

LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 12, 2024

DJ LivaNova Price Target Maintained With a $75.00/Share by Needham, from 11:07AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 11, 2024

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints, from 4:05PM ET on Monday Nov 11, 2024 by Dow Jones

Oct 31, 2024

DJ LivaNova Is Maintained at Outperform by Mizuho, from 10:41AM ET on Thursday Oct 31, 2024 by Dow Jones

DJ LivaNova Is Maintained at Outperform by Baird, from 7:51AM ET on Thursday Oct 31, 2024 by Dow Jones

Peers Headlines

Nov 20, 2024

Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing, from 5:31PM ET on Wednesday Nov 20, 2024 by MT Newswires

Nov 19, 2024

DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 12:16PM ET on Tuesday Nov 19, 2024 by Dow Jones

INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Newsfile

INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm, from 8:52AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference, from 4:05PM ET on Monday Nov 18, 2024 by Dow Jones

Nov 13, 2024

Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Newsfile

Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 8, 2024

DJ Warby Parker Is Maintained at Outperform by Telsey Advisory Group, from 6:09PM ET on Friday Nov 08, 2024 by Dow Jones

UBS Adjusts Price Target on Warby Parker to $20 From $15, Maintains Neutral Rating, from 11:55AM ET on Friday Nov 08, 2024 by MT Newswires

DJ Warby Parker Is Maintained at Overweight by Piper Sandler, from 9:41AM ET on Friday Nov 08, 2024 by Dow Jones